Joyce M. van Dodewaard-de Jong

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld et al. · The Lancet Oncology · 2023 · 168 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16

Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based study

Seyed M. Qaderi, J. Van Der Heijden, Rob H.A. Verhoeven et al. · European Journal of Cancer · 2021 · 54 citations · Full text

Pharmacy, Oncology, Cancer Symptom Management +16

Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT

Esther W. Bouman-Wammes, Joyce M. van Dodewaard-de Jong, Max Dahele et al. · Clinical Genitourinary Cancer · 2017 · 41 citations

Medicine, Nuclear Medicine, Oncology +15

The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care

Jeroen W. G. Derksen, Geraldine R. Vink, Marloes A.G. Elferink et al. · Scientific Reports · 2021 · 39 citations · Full text

Medicine, Biostatistics, Oncology +14

A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)

Joyce M. van Dodewaard-de Jong, John M. H. de Klerk, Haiko J. Bloemendal et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 31 citations

Medicine, Oncology, Pharmacology +16